What Pre-Operative Evaluation Protocols Should Clinical Staff Establish Before Performing Fractional Laser Resurfacing Procedures? Essential Safety Measures For Optimal Outcomes

Before fractional laser resurfacing, clinical staff should use a standardized, documented pre-operative assessment covering treatment goals, skin and scar characteristics, medical history, infection and scarring risks, medications, skin preparation, ocular safety, and informed consent. The protocol should be adapted to whether treatment is non-ablative or ablative, the treatment area, the patient’s phototype, and the planned treatment intensity.

Fractional laser safety depends less on the device alone than on selecting appropriate patients, identifying preventable risks, and documenting a baseline against which treatment response and complications can be assessed.

Establish a Structured Consultation and Consent Process

Define the treatment objective

Document the specific indication, such as acne scars, traumatic scars, surgical scars, rhytides, or photodamage. Staff should clarify the patient’s desired degree of improvement and explain that fractional resurfacing generally produces improvement rather than complete correction.

Discuss the expected number of sessions, approximate recovery period, need for maintenance, and the possibility that treatment parameters may need to be reduced or staged.

Explain material risks and limitations

Written consent should address expected effects such as erythema, edema, discomfort, crusting, temporary pigmentary changes, and prolonged healing. It should also cover less common but important risks, including post-inflammatory hyperpigmentation, infection, HSV reactivation, delayed healing, scarring, and ectropion when treating near the eyelids.

Consent should be signed before treatment and supported by written pre- and post-procedure instructions.

Document baseline photographs and findings

Standardized photographs should record the treatment area before intervention. The clinical record should also describe baseline photodamage, pigmentation, erythema, texture, and scar morphology.

Photographic and examination baselines help staff assess treatment response and distinguish pre-existing findings from post-operative complications.

Complete the Medical and Risk History

Review skin type and pigmentary risk

Record the patient’s skin phototype and history of abnormal pigmentation, particularly prior post-inflammatory hyperpigmentation. Patients with darker phototypes may require conservative energy settings, careful sun avoidance, and, when clinically appropriate, pre-treatment pigment management.

The protocol should also document recent tanning, ongoing sun exposure, and the patient’s ability to comply with strict photoprotection.

Screen for HSV and active infection

Ask specifically about oral or facial herpes simplex, previous laser-triggered outbreaks, and current lesions. Patients with active herpes lesions in the treatment area should be postponed until the infection has fully cleared.

For facial non-ablative or ablative fractional resurfacing, clinicians should establish a protocol for antiviral prophylaxis in patients with a relevant HSV history. The medication, timing, and duration should follow the treating clinician’s judgment and applicable local guidance.

Assess abnormal scarring

Document any history of hypertrophic scars or keloids, including the location and severity of previous reactions. This is particularly important before high-energy ablative treatment or treatment of areas already showing scar abnormalities.

A strong history of problematic scarring may require alternative treatment, lower-intensity staged treatment, specialist review, or a decision not to proceed.

Review medical conditions and medications

The history should include conditions that may impair healing or increase infection, bleeding, or pigmentary risk. Review all prescription medicines, over-the-counter products, supplements, anticoagulants, photosensitizing agents, and immunosuppressive therapies.

Staff should specifically identify recent systemic isotretinoin or other systemic retinoid exposure. The supplementary material recommends discontinuing systemic retinoids six to twelve months before treatment; because timing depends on the drug, procedure, and current evidence, this should be confirmed by the responsible clinician rather than applied automatically.

Record allergies and prior anesthetic reactions

Document allergies to medications, topical anesthetics, adhesives, antiseptics, antibiotics, antivirals, and other materials likely to be used. Include any previous reactions to local anesthesia, sedation, or general anesthesia where relevant.

Examine the Treatment Area in Detail

Characterize scars before treatment

For scar resurfacing, document each scar’s:

Thickness
Pliability
Erythema
Texture
Elevation or depression
Restriction of movement
Relationship to nearby structures

These findings help determine whether fractional laser is appropriate and provide a clinically meaningful baseline for follow-up.

Assess photodamage and skin integrity

Examine for photodamage, active dermatitis, inflammation, open wounds, abrasions, acne flares, bacterial infection, and viral lesions. Treatment should be deferred when the skin barrier is compromised or infection is present in the treatment field.

Record the extent and severity of photodamage so that treatment expectations and settings can be individualized.

Perform an eyelid assessment when indicated

When treating the periorbital region, perform an eyelid snap test to assess skin elasticity. Reduced elasticity or eyelid laxity may increase the risk of post-procedure ectropion.

The assessment should also consider prior eyelid or periorbital surgery, altered anatomy, and the planned treatment depth.

Review prior procedures

Document previous laser treatments, chemical peels, dermabrasion, fillers, surgery, radiation, and other procedures affecting the treatment area. Prior interventions may alter healing, anatomy, pigmentation, or scar behavior.

Prepare the Skin and Medications

Confirm sun avoidance and photoprotection

Patients should avoid tanning and unnecessary direct sun exposure before treatment. The protocol should specify when treatment will be postponed because of recent tanning or inadequate photoprotection.

Patients must understand that sun avoidance remains essential after treatment because ultraviolet exposure increases the risk of abnormal pigmentation.

Stop irritating topical products

Topical retinoids, exfoliants, and alpha-hydroxy-acid products should be stopped before treatment according to the clinician’s protocol and product instructions. The supplied references describe discontinuation periods ranging from several days to approximately two weeks, so clinics should adopt one clear, evidence-based interval rather than give inconsistent instructions.

Patients should also disclose topical bleaching or pigment-lightening products and other active skincare agents.

Consider pre-treatment conditioning selectively

For selected patients, particularly those at increased risk of hyperpigmentation, clinicians may consider pigment-lightening or other skin-conditioning measures before resurfacing. Mild exfoliation or retinoid conditioning may be used in some protocols, but it should not be continued close to treatment and is not appropriate for every patient.

Skin conditioning should be individualized, documented, and stopped early enough to restore a stable skin barrier.

Plan infection prophylaxis when appropriate

For extensive ablative treatments, especially full-face or neck resurfacing, the clinician may establish protocols for prophylactic antiviral and antibacterial medication. The supplementary material describes starting these medications one day before treatment and continuing them for several days afterward, but antibiotic use should be based on the procedure, patient risk, local policy, and prescriber judgment rather than treated as universally mandatory.

Verify Procedure-Specific Readiness

Differentiate non-ablative and ablative protocols

Non-ablative fractional resurfacing preserves the stratum corneum and usually has faster healing, but staff must still evaluate phototype, pigmentary risk, HSV history, medications, and skin integrity.

Ablative fractional resurfacing creates deeper tissue injury and requires more rigorous assessment of infection risk, healing capacity, anesthesia needs, plume control, and post-treatment support.

Use test spots for aggressive treatment

For aggressive procedures such as fractional CO₂ resurfacing, a test spot at least two weeks before full treatment can help assess tissue response in selected patients. This is especially useful when treatment parameters are uncertain or when the patient has increased pigmentary or scarring risk.

Unexpected intense whitening or gray discoloration during a test or treatment indicates a strong thermal response and should prompt reassessment of fluence, density, pulse overlap, or other parameters.

Confirm anesthesia and pain-control planning

The pre-operative checklist should identify the planned anesthesia method, allergies, contraindications, monitoring requirements, and recovery arrangements. Options may include topical anesthetic, oral or intramuscular sedation, regional nerve blocks, or general anesthesia depending on treatment depth and extent.

If topical anesthetic is used, staff should follow a controlled application and removal process before laser delivery to reduce medication-related risks.

Verify ocular protection

The protocol must specify eye protection for the wavelength and treatment location. Internal stainless-steel ocular shields are required when treating eyelid skin, while external wavelength-appropriate goggles or shields are used for other facial areas when appropriate.

Periorbital treatment should not begin until the correct protection is in place and the eyelid assessment has been documented.

Prepare the Treatment Environment

Control laser plume

Ablative resurfacing generates aerosolized tissue plume. A dedicated, high-efficiency smoke evacuator should operate continuously during treatment, with the capture device positioned close to the treatment field.

Staff should follow applicable infection-control and occupational-safety requirements for plume exposure.

Control access and identify the laser area

The treatment room should have visible laser warning signage and restricted access during operation. Only trained, authorized personnel should be present.

The pre-procedure check should confirm device readiness, appropriate settings, emergency equipment, protective eyewear, and availability of the planned medications and dressings.

Confirm patient and procedure details

Immediately before treatment, verify the patient’s identity, treatment area, indication, consent, planned device and wavelength, intended settings, allergies, medications, and antiviral or other prophylaxis plan.

The final time-out should also confirm that active infection, recent tanning, contraindicated medication exposure, and unaddressed ocular or scarring risks are absent.

Understanding the Trade-offs

More aggressive treatment is not automatically better

Higher fluence, density, or pulse overlap may increase resurfacing effect but also increases thermal injury, downtime, pigmentary complications, infection risk, and potential scarring. Staged or conservative treatment may provide a safer path when the patient has darker skin, poor healing risk, or uncertain scar behavior.

Antibiotic and antiviral plans require judgment

Antiviral prophylaxis is particularly important for patients with HSV risk and facial treatment, but medication selection and timing require clinician oversight. Routine systemic antibiotics should not replace assessment of infection risk or local antimicrobial policy.

Test spots reduce uncertainty but do not eliminate risk

A test spot can reveal an excessive tissue response or pigmentary tendency, but it cannot guarantee that a larger treatment area will heal identically. Staff should still reassess the patient immediately before full treatment.

Skin preparation can create its own irritation

Retinoids, exfoliants, and pigment-lightening agents may support selected preparation plans, but overuse or inadequate discontinuation can compromise the barrier and increase irritation. A simple, documented regimen is safer than an overly aggressive one.

How to Apply This to Your Clinic

A practical protocol should use a standardized form and a documented clinician sign-off before any fractional resurfacing session.

If your primary focus is patient selection: Require documentation of treatment goals, phototype, HSV history, scarring tendency, medical conditions, medications, allergies, active skin disease, and prior periorbital surgery.
If your primary focus is complication prevention: Add defined criteria for postponing treatment, antiviral prophylaxis, medication discontinuation, sun avoidance, and test-spot evaluation.
If your primary focus is periorbital treatment: Make the eyelid snap test, ocular protection, eyelid-surgery history, and ectropion-risk assessment mandatory.
If your primary focus is ablative resurfacing: Confirm anesthesia, plume evacuation, infection-control measures, access restrictions, and a procedure-specific recovery plan before starting.
If your primary focus is documentation and consent: Record standardized photographs, scar and photodamage findings, planned settings, alternatives, expected downtime, risks, and the patient’s signed informed consent.

A robust pre-operative protocol turns fractional laser resurfacing from a device-driven procedure into a controlled clinical decision based on patient risk, treatment goals, and documented readiness.

Summary Table:

Protocol Component	Key Actions	Purpose
Structured consultation	Define goals, discuss risks/benefits, obtain written consent	Set realistic expectations and ensure informed consent
Medical history review	Assess skin type, HSV risk, scarring tendency, medications, allergies	Identify contraindications and prevent complications
Treatment area examination	Characterize scars, assess photodamage, eyelid snap test if periorbital	Establish baseline and tailor treatment
Skin preparation	Sun avoidance, discontinue irritating products, consider prophylaxis	Optimize skin barrier and reduce adverse events
Procedure-specific readiness	Test spots, anesthesia planning, ocular protection, plume control	Ensure safe execution of the procedure

Ensure your clinic's fractional laser procedures are safe and effective with BELIS's advanced medical aesthetic equipment, designed exclusively for clinics and premium salons. Our portfolio includes state-of-the-art fractional CO2, Erbium, and other laser systems, supported by comprehensive training and OEM/ODM services. Contact us today to elevate your practice and deliver exceptional patient care. Contact us to learn more.